| Literature DB >> 27829937 |
Andrzej Kwiatkowski1, Michał R Janik1, Krzysztof Paśnik1, Edward Stanowski1.
Abstract
INTRODUCTION: Laparoscopic sleeve gastrectomy (LSG) is one of the most popular bariatric procedures. The procedure is associated with serious staple-line complications such as bleeding, leaks, and stenosis. AIM: To determine whether oversewing the staple line, compared with clipping, in LSG reduces the incidence of postoperative bleeding.Entities:
Keywords: bleeding; leak; oversewing; reinforcement; sleeve gastrectomy; staple line
Year: 2016 PMID: 27829937 PMCID: PMC5095279 DOI: 10.5114/wiitm.2016.62801
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Figure 1Flow diagram
Baseline characteristics
| Patient characteristic | Intervention groups | ||
|---|---|---|---|
| Oversewing ( | Clipping ( | ||
| Age [years] | 36.8 ±10.3 | 39.5 ±10.5 | 0.26 |
| BMI [kg/m2] | 49.0 ±8.5 | 45.7 ±9.0 | 0.14 |
| Sex ratio, female/male | 27/23 | 19/24 | 0.41 |
| Previous abdominal non-bariatric surgery | 5 (10%) | 7 (16%) | 0.53 |
| Comorbidities: | |||
| Hypertension | 26 (52%) | 17 (39%) | 0.29 |
| Diabetes | 10 (20%) | 9 (21%) | 1.0 |
| Dyslipidemia | 5 (10%) | 4 (9%) | 1.0 |
Data expressed as mean ± standard deviation, n, or n (%).
Student’s t test.
Mann-Whitney U test.
Fisher’s exact test. BMI – body mass index.
Stapler data
| Stapler manufacturer | Intervention groups | ||
|---|---|---|---|
| Oversewing | Clipping | ||
| Ethicon/ Covidien | 27/23 | 24/19 | 1.0 |
Fisher’s exact test.
Prevalence of primary outcome in both groups
| Primary outcome | Intervention groups | Risk ratio (95% CI) | ||
|---|---|---|---|---|
| Oversewing ( | Clipping ( | |||
| Reoperation due to staple-line bleeding | 0 (0%) | 2 (4.6%) | 0.21 | Not estimable |
Fisher’s exact test. CI – confidence interval.
Prevalence of secondary outcomes in both groups
| Secondary outcomes | Intervention groups | ||
|---|---|---|---|
| Oversewing ( | Clipping ( | ||
| Operative duration [min] | 78.2 ±20.5 | 64.1 ±16.5 | < 0.01 |
| Length of hospital stay [days] | 3.2 ±0.4 | 3.6 ±1.3 | 0.32 |
| Postoperative leakage | 0 (0.0%) | 1 (2.3%) | 0.46 |
| Postoperative stenosis | 0 (0%) | 1 (2.3%) | 0.46 |
Data expressed as mean ± standard deviation or n (%).
Mann-Whitney U test.
Fisher’s exact test.
Significant value.
Literature review: randomized controlled trials
| Author, year | Group ( | Intervention | Outcomes | Conclusion (statistically significant difference between/among groups) | ||
|---|---|---|---|---|---|---|
| Staple-line bleeding | Stenosis | Gastric leak | ||||
| Carandina | A (150) | No SLR | 1 | 2 | 3 | No |
| B (150) | SLR with fibrin glue | 2 | 2 | 4 | ||
| C (150) | Imbricating absorbable running suture | 1 | 1 | 3 | ||
| D (150) | Barbed running suture | 1 | 2 | 4 | ||
| Aggarwal | A (30) | Running suture | 0 | 0 | 0 | No |
| B (30) | No SLR | 1 | 0 | 2 | ||
| Gentileschi | A (35) | Running suture | 1 | 0 | 1 | No |
| B (34) | GORE SEAMGUARD | 1 | 0 | 0 | ||
| C (33) | FLOSEAL | 0 | 0 | 1 | ||
| Musella | A (50) | 3-0 polypropylene running suture | 4 | 4 | 1 | Bleeding, leaks: No |
| B (50) | No SLR | 2 | 0 | 2 | ||
| Albanopoulos | A (48) | Gore seamguard | 1 | NA | 2 | No |
| B (42) | 2-0 PDS running suture | 0 | NA | 0 | ||
| Dapri | A (25) | No SLR | NA | NA | 1 | No |
| B (25) | GORE SEAMGUARD | NA | NA | 2 | ||
| C (25) | Running suture | NA | NA | 1 | ||
| Present study | Clipping (50) | No SLR (clipping) | 2 | 1 | 1 | No |
| Oversewing (50) | 3-0 Biosync continuous extraserosal invaginating suture | 0 | 0 | 0 | ||
Gore Medical/W.L. Gore & Associates, Inc., Flagstaff, AZ, USA.
Baxter Healthcare Corp., Deerfield, IL, USA.
cCovidien/Medtronic, Inc., Mansfield, MA, USA. SLR – staple-line reinforcement.